SeaStar Medical Holding Corporation (ICUCW) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4

Key dataNov 4, 2026

Open$0.01

From 52W high−70.88%

Volume1.00

Market cap$32199.95

P/E (TTM)—

P/S (TTM)0.0x

Div yield—

Key dataNov 4, 2026

Open

$0.01

From 52W high

−70.88%

Volume

1.00

Market cap

$32199.95

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

0.7x

P/E (TTM)

—

RSI (14)

34.0

MomentumView details →

1D Return

+15.09%

YTD Return

−6.19%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

0.7x

EV/Sales

−4.0x

P/S (TTM)

0.0x

P/B (TTM)

0.0x

ProfitabilityView details →

Gross Margin

92.64%

Net Margin

−795.50%

EBITDA Margin

−589.32%

ROE (TTM)

−317.20%

ROA (TTM)

−157.56%

Asset Turnover

0.17x

GrowthView details →

Revenue YoY

+123.63%

EPS YoY

+84.67%

FCF YoY

+10.83%

Revenue CAGR 3Y

+814.07%

EPS CAGR 3Y

+91.16%

EBITDA YoY

+30.99%

MomentumView details →

1D Return

+15.09%

YTD Return

−6.19%

1Y Return

−73.03%

RSI (14)

34.0

vs 50D SMA

−34.46%

vs 200D SMA

−50.28%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

1.89x

Quick Ratio

1.87x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.91

EPS Surprise

6.19%

Beats (12Q)

5/12

Next Q EPS Est

−$0.89

Avg Surprise (4Q)

28.56%

Rev Surprise

26.41%

Financials snapshotView financials →

Revenue (TTM)

1.71M

Net Income (TTM)

−13.63M

Op. CF (TTM)

−13.69M

Next earningsNov 18, 2026 →

Latest newsMore news →

SeaStar Medical Holding Corp announced that it will report third-quarter 2026 financial results after market close on November 11, 2026, and host a webcast and conference call.7h ago

The FDA determined that SeaStar Medical's QUELIMMUNE Pediatric SAVE Surveillance Registry fulfilled the post-approval study requirements in the device's original Humanitarian Device Exemption approval.1d ago

Similar companies

Revelation Biosciences, Inc.REVBW Coeptis Therapeutics Holdings, Inc.COEPW Carisma Therapeutics, Inc.CARM Pasithea Therapeutics Corp.KTTAW Cardio Diagnostics Holdings, Inc.CDIOW Celularity Inc.CELUW Find similar companies →

Latest newsMore news →

SeaStar Medical Holding Corp announced that it will report third-quarter 2026 financial results after market close on November 11, 2026, and host a webcast and conference call.7h ago The FDA determined that SeaStar Medical's QUELIMMUNE Pediatric SAVE Surveillance Registry fulfilled the post-approval study requirements in the device's original Humanitarian Device Exemption approval.1d ago